Skip to main content
. 2018 Jan 31;8:210–221. doi: 10.1016/j.omtm.2018.01.010

Figure 1.

Figure 1

Schematic Depiction of the Adoptive T Cell Immunotherapy Process for Tumor-Infiltrating Lymphocyte or Engineered T Cell Therapy

HHS Vulnerability Disclosure